2 Biotech Stocks Poised for Jaw-Dropping Gains
Biotech companies early in the process of drug development have proved to be an extremely fruitful area for investors on the hunt for life-changing growth opportunities. In fact, the 10 best-performing stocks every year for the past decade have consisted largely of clinical-stage biotechs.
Which developmental biotechs should aggressive investors have on their radar screens? Atreca (NASDAQ: BCEL) and Crinetics Pharmaceuticals (NASDAQ: CRNX) are two names with explosive growth potential in the years ahead. Here's a brief overview on each company.
Image source: Getty Images.
Source Fool.com
